A practical guide for clinicians on cannabis use by IBD patients, including clinical vignettes
While cannabis may help manage some IBD symptoms, it has not been proven to reduce inflammation, and clinicians should be aware of dosing inconsistencies, dependence risks, and cannabinoid hyperemesis syndrome.
Quick Facts
What This Study Found
Cannabis has gained popularity for IBD symptom management but has not been proven to reduce inflammation or correct underlying disease processes. Key concerns include dosing inconsistencies across products, risk of dependence, and cannabinoid hyperemesis syndrome.
Key Numbers
15 U.S. states regulate adult cannabis use; 36 states for medical use; cannabis has not been proven to help with IBD inflammation
How They Did This
Review article summarizing current research on cannabis and IBD, supplemented with clinical vignettes illustrating practical considerations for clinicians.
Why This Research Matters
As more IBD patients turn to cannabis, clinicians need practical guidance on discussing its potential benefits and limitations, especially distinguishing symptom relief from disease modification.
The Bigger Picture
The disconnect between patient enthusiasm for cannabis and the limited evidence for its efficacy in IBD represents a common pattern across many chronic conditions where patients seek alternatives to conventional treatment.
What This Study Doesn't Tell Us
Narrative review without systematic methodology. Clinical vignettes illustrate but do not provide evidence. Limited by the small number of available clinical studies on cannabis for IBD.
Questions This Raises
- ?Should gastroenterologists proactively discuss cannabis with IBD patients?
- ?How should clinicians monitor patients who use cannabis alongside IBD medications?
- ?What standardized guidance can be developed for this common clinical scenario?
Trust & Context
- Key Stat:
- Cannabis has not been proven to reduce IBD inflammation
- Evidence Grade:
- Narrative review with clinical vignettes for practical guidance
- Study Age:
- Published in 2021. Cannabis use among IBD patients continues to increase as access expands.
- Original Title:
- Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.
- Published In:
- Advances in therapy, 38(7), 4152-4161 (2021)
- Authors:
- Buckley, Megan C, Kumar, Anand, Swaminath, Arun(3)
- Database ID:
- RTHC-03030
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Should IBD patients use cannabis?
Cannabis may help manage some symptoms like pain, but has not been proven to reduce the inflammation underlying IBD. Patients should discuss potential benefits and risks with their gastroenterologist.
What risks should IBD patients know about cannabis?
Key concerns include dosing inconsistencies between products, risk of dependence with chronic use, and cannabinoid hyperemesis syndrome, which paradoxically causes severe vomiting in some chronic users.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03030APA
Buckley, Megan C; Kumar, Anand; Swaminath, Arun. (2021). Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.. Advances in therapy, 38(7), 4152-4161. https://doi.org/10.1007/s12325-021-01805-8
MLA
Buckley, Megan C, et al. "Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.." Advances in therapy, 2021. https://doi.org/10.1007/s12325-021-01805-8
RethinkTHC
RethinkTHC Research Database. "Inflammatory Bowel Disease and Cannabis: A Practical Approac..." RTHC-03030. Retrieved from https://rethinkthc.com/research/buckley-2021-inflammatory-bowel-disease-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.